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Abstract
Background: Trypanosoma brucei brucei infects livestock, with severe effects in horses and dogs. Mouse strains differ greatly
in susceptibility to this parasite. However, no genes controlling these differences were mapped.
Methods: We studied the genetic control of survival after T. b. brucei infection using recombinant congenic (RC) strains,
which have a high mapping power. Each RC strain of BALB/c-c-STS/A (CcS/Dem) series contains a different random subset of
12.5% genes from the parental ‘‘donor’’ strain STS/A and 87.5% genes from the ‘‘background’’ strain BALB/c. Although
BALB/c and STS/A mice are similarly susceptible to T. b. brucei, the RC strain CcS-11 is more susceptible than either of them.
We analyzed genetics of survival in T. b. brucei-infected F2 hybrids between BALB/c and CcS-11. CcS-11 strain carries STS-
derived segments on eight chromosomes. They were genotyped in the F2 hybrid mice and their linkage with survival was
tested by analysis of variance.
Results: We mapped four Tbbr (Trypanosoma brucei brucei response) loci that influence survival after T. b. brucei infection.
Tbbr1 (chromosome 3) and Tbbr2 (chromosome 12) have effects on survival independent of inter-genic interactions (main
effects). Tbbr3 (chromosome 7) influences survival in interaction with Tbbr4 (chromosome 19). Tbbr2 is located on a segment
2.15 Mb short that contains only 26 genes.
Conclusion: This study presents the first identification of chromosomal loci controlling susceptibility to T. b. brucei infection.
While mapping in F2 hybrids of inbred strains usually has a precision of 40–80 Mb, in RC strains we mapped Tbbr2 to a
2.15 Mb segment containing only 26 genes, which will enable an effective search for the candidate gene. Definition of
susceptibility genes will improve the understanding of pathways and genetic diversity underlying the disease and may
result in new strategies to overcome the active subversion of the immune system by T. b. brucei.
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Introduction
Sleeping sickness (African trypanosomiasis) continues to pose a
major threat to 60 million people in 36 countries in sub-Saharan
Africa. The estimated number of new cases is currently between
50 000 and 70 000 per year (WHO 2006 – African trypanoso-
miasis - http://www.who.int/mediacentre/factsheets/fs259/en/).
The disease is caused by infection with the tsetse fly-transmitted
[1] protozoan haemoflagellate Trypanosoma brucei, which has three
major sub-species: T. b. gambiense, T. b. rhodesiense and T. b. brucei.
Two of them, T. b. gambiense and T. b. rhodesiense cause sleeping
sickness in humans and can also infect animals; thus domestic and
wild animals are an important parasite reservoir (WHO 2006 -
http://www.who.int/mediacentre/factsheets/fs259/en/). The
third species, T. b. brucei infects a wide range of mammals,
but is unable to infect humans because it lacks the SRA (serum
resistance-associated) protein that prevents lysis induced by
Apolipoprotein L1, which is present in normal human serum
[2,3]. T. b. equiperdum and T. b. evansi, which are derived from T.
b. brucei, are adapted to transmission without development in
tsetse fly, allowing these parasites to spread outside the African
tsetse belt [4].
Upon the bite of the mammalian host by trypanosome-infected
tsetse fly (Glossina ssp.), the parasites multiply locally in the skin and
elicit a local host response in the form of an indurated skin lesion
called the chancre. Eventually, the parasites enter the blood
circulation via lymph vessels and can survive in the blood
circulation throughout the infection of the host (reviewed in
www.plosntds.org 1 June 2011 | Volume 5 | Issue 6 | e1173[5,6]), remaining continually exposed to the host’s immune system.
T. brucei species have the ability to penetrate the walls of capillaries
and invade interstitial tissues, but they always remain extracellular
as opposed to T. cruzi [6]. During the meningo-encephalitic phase
of the infection parasites pass into brain where they cause serious
pathology [7].
African trypanosomes have evolved very sophisticated evasion
mechanisms to survive in chronically infected host. These evasion
mechanisms include antigenic variation of the variant surface
glycoprotein (VSG) [8] and the induction of alterations in the
host’s defense system, such as excessive activation of the
complement system leading to persistent hypocomplementemia
[9], anemia, thrombocytopenia [9], down regulation of nitric
oxide production [10], polyclonal B-lymphocyte activation [11],
and marked immunosuppression [12,13]. Most likely African
trypanosomes induce also other, yet undiscovered, changes in the
physiology of the infected host, which might interfere with effective
control of the parasite [6].
Due to genetic and biological relatedness of T. b. brucei to other
Trypanosoma species, many host responses to their infections are
shared and therefore many aspects of human African trypanoso-
miasis (HAT) as well as livestock and horses infections are studied
in experimental mouse infection with T. b. brucei. These
experiments revealed great genetic variability among mouse
strains in response to T. b. brucei, however not all results can be
compared with each other because they were obtained in different
experimental conditions using different T. b. brucei isolates. Strains
DBA/2, BALB/c, BALB.B, and C3H/He are susceptible to T. b.
brucei and display higher parasitemia, survive for a shorter time,
whereas strains C57BL/10, C57BL/6, and B10.D2 are relatively
resistant and survive a longer time [14,15]. In another experiment
BALB/c mice exhibited higher parasitemia than C57BL/6, but
they did not differ in survival [16]. Comparison of C57BL/6 and
129/SvEv showed that 129/SvEv exhibited higher parasitemia
and lower specific IgM (but not IgG) antibody levels than C57BL/
6 mice. Parasitemia was higher in 129Sv/Ev, but the weight loss,
mortality and the number of trypanosomes in brain was higher in
C57BL/6 [7]. CBA/N mice, deficient in production of a thymus-
dependent high affinity antibody subset [17] survived longer than
the strains CBA/CaT6 and A/J and had slightly lower
splenomegaly, but all three strains exhibited similar numbers of
circulating parasites [18].
Mouse genes controlling susceptibility to trypanosomiasis
caused by the subgenus T. (Nannomonas) congolense [19–22] and by
sub-genus T. (Schizotrypanum) cruzi the causative agent of Chagas
disease [23], have been successfully mapped, but a genome-wide
search for susceptibility loci to the subgenus T. (Trypanozoon) brucei
has not yet been attempted.
We have therefore analyzed the genetic control of T. b. brucei
resistance using the recombinant congenic (RC) strains of the
BALB/c-c-STS/Dem (CcS/Dem) series. This series comprises 20
homozygous strains all derived from two parental inbred strains:
the ‘‘background’’ strain BALB/c and the ‘‘donor’’ strain STS.
Each CcS/Dem strain contains a different, random set of
approximately 12.5% genes of the donor strain STS and
approximately 87.5% genes of the background strain BALB/c
[24]. This series has been successfully used to study genetics of
complex diseases (partly reviewed in van Wezel et al. 2001 [25]),
including infection with Leishmania major [26–30] and Bordetella
pertussis [31].
In the present work, we show that RC strain CcS-11 differs in
survival from both parental strains BALB/c and STS. In the cross
between BALB/c and CcS-11, we mapped four genetic loci that
influence survival after T. b. brucei infection. Two of these loci have
individual effects; the other two operate in mutual non-additive
interaction. This is the first report of genetic loci controlling
resistance to T. b. brucei.
Materials and Methods
Mice
Mice of strains tested for survival BALB/cHeA (BALB/c) (10
females, 10 males), STS/A (10 females, 10 males), CcS-5 (10
females, 10 males), CcS-11 (10 females, 10 males), CcS-16 (9
females, 9 males) and CcS-20 (10 females, 10 males) were 13 to 23
weeks old (mean 17, median 17) at the time of infection.
Splenomegaly, hepatomegaly, body weight changes and serum
levels of seven cytokines and chemokines were analyzed using
females of BALB/c (22 infected, 22 non-infected), STS (17
infected, 13 non-infected) and CcS-11 (25 infected, 26 non-
infected), which were 8 to 19 week old (mean 13, median 13) at the
time of infection. When used for these experiments, CcS/Dem
strains passed more then 38 generation of inbreeding and
therefore were highly homozygous. The regions of RCS’ genomes
inherited from the BALB/c or STS parents were defined [32]. 169
F2 hybrids between CcS-11 and BALB/c (age 22 and 23 weeks at
the time of infection) were produced at the Institute of Molecular
Genetics. They comprised 85 females and 84 males and were
tested simultaneously as a single experimental group. During the
experiment, mice were placed into individually ventilated cages
behind a barrier. The research had complied with all relevant
European Union guidelines for work with animals and was
approved by the Institutional Animal Care Committee of the
Institute of Molecular Genetics AS CR and by Departmental
Expert Committee for the Approval of Projects of Experiments on
Animals of the Academy of Sciences of the Czech Republic.
Parasites
The strain of Trypanosoma brucei brucei (AnTar1) was a generous
gift of Jan van den Abbeele, Institute of Tropical Medicine ‘‘Prince
Leopold’’, Antwerp, Belgium. Parasites stored in liquid nitrogen
were thawed and used to infect BALB/c males by intraperitoneal
Author Summary
Trypanosoma brucei are extracellular protozoa transmitted
to mammalian host by the tsetse fly. They developed
several mechanisms that subvert host’s immune defenses.
Therefore analysis of genes affecting host’s resistance to
infection can reveal critical aspects of host-parasite
interactions. Trypanosoma brucei brucei infects many
animal species including livestock, with particularly severe
effects in horses and dogs. Mouse strains differ greatly in
susceptibility to T. b. brucei. However, genes controlling
susceptibility to this parasite have not been mapped. We
analyzed the genetic control of survival after T. b. brucei
infection using CcS/Dem recombinant congenic (RC)
strains, each of which contains a different random set of
12.5% genes of their donor parental strain STS/A on the
BALB/c genetic background. The RC strain CcS-11 is even
more susceptible to parasites than BALB/c or STS/A. In F2
hybrids between BALB/c and CcS-11 we detected and
mapped four loci, Tbbr1-4 (Trypanosoma brucei brucei
response 1–4), that control survival after T. b. brucei
infection. Tbbr1 (chromosome 3) and Tbbr2 (chromosome
12) have independent effects, Tbbr3 (chromosome 7) and
Tbbr4 (chromosome 19) were detected by their mutual
inter-genic interaction. Tbbr2 was precision mapped to a
segment of 2.15 Mb that contains 26 genes.
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collected, diluted in 90 ml of 1% formaldehyde in PBS, and the
trypanosomes were counted in a Bu ¨rker counting chamber.
Subsequently, tail blood was diluted in RPMI containing L-
glutamine, sodium bicarbonate and glucose (Cat. Nr. R8758,
Sigma, St. Louis, MO) in order to contain appropriate numbers of
parasites for inoculation (Please see below).
Trypanosomiasis challenge
Mice were inoculated intraperitoneally with 2.5610
4 blood-
stream forms of T. b. brucei (AnTar1 strain) in 50. ml of RPMI
containing L-glutamine, sodium bicarbonate and glucose (Cat. Nr.
R8758, Sigma, St. Louis, MO). Survival time was measured in
days following the day of challenge (day 0).
Disease phenotype
In the mice infected with T. b. brucei,9 0 ml of blood were
obtained 2 days after infection for determination of cytokine and
chemokine levels. Mice were killed 10 days after inoculation. The
blood, spleen, and liver were collected for the further analysis.
Cytokine and chemokine levels
Levels of GM-CSF (granulocyte-macrophage colony-stimulat-
ing factor), CCL2 (chemokine (C-C motif) ligand 2)/MCP-1
(monocyte chemotactic protein-1), CCL3/MIP-1a (macrophage
inflammatory protein-1a), CCL4/MIP-1b (macrophage inflam-
matory protein 1-b), CCL5/RANTES (regulated upon activation,
normal T-cell expressed, and secreted), CCL7/MCP-3 (monocyte
chemotactic protein-3) and TNF-a, in serum were determined
using Mouse chemokine 6-plex kit (Bender MedSystems, Vienna,
Austria) and Mouse TNF-a simplex kit as multiplex assay. The kit
contains two sets of beads of different size internally dyed with
different intensities of fluorescent dye. The set of small beads is
used for GM-CSF, CCL5/RANTES, CCL4/MIP-1b and TNF-a
and set of large beads for CCL3/MIP-1a, CCL2/MCP-1 and
CCL7/MCP-3. The beads are coated with antibodies specifically
reacting with each of the analytes (chemokines) to be detected in
the multiplex system. A biotin secondary antibody mixture binds
to the analytes captured by the first antibody. Streptavidin –
Phycoerythrin binds to the biotin conjugate and emits fluorescent
signal. Test procedure was performed in the 96 well filter plates
(Millipore, Billerica, MA, USA) according to the protocol of
Bender MedSystem. Beads were analyzed on flow cytometer LSR
II (BD Biosciences, San Jose, CA, USA). Concentrations of
cytokines were determined by Flow Cytomix Pro 2.4 software.
The limit of detection of each analyte was determined to be for
GM-CSF 12.2 pg/ml, CCL2/MCP-1 42 pg/ml, CCL7/MCP-3
1.4 pg/ml, CCL3/MIP-1a 1.8 pg/ml, CCL4/MIP-1b 14.9 pg/
ml, CCL5/RANTES 6.1 pg/ml, TNF-a2.1 pg/ml respectively.
Genotyping of F2 mice
DNA was isolated from tails using a standard proteinase
procedure. The strain CcS-11 differs from BALB/c at STS-derived
regions on eight chromosomes [32]. These differential regions were
typed in the F2 hybrid mice between CcS-11 and BALB/c using 14
microsatellite markers (Research Genetics, Huntsville, AL, and
Generi Biotech, Hradec Kra ´love ´, Czech Republic): D1Mit403,
D3Mit45, D7Mit25, D7Mit18, D7Mit282, D7Mit259, D8Mit85,
D10Mit46, D10Mit12, D12Mit37, D16Mit73, D19Mit51,
D19Mit60 and D19Mit46 (Table S1). The average distance
between any two markers in the chromosomal segments derived
from the strain STS or from the nearest BALB/c derived markers
was 8.7 cM. DNA was amplified in a 20-ml PCR reaction with
0.11 mM of forward and reverse primer, 0.2 mM concentration of
each dNTP, 1.5 mM MgCl2 (except marker D7Mit259, for which
theoptimalconcentrationwas 2.5 mM), 50 mMKCl, 10 mMTris-
HCl (pH 8.3), and 0.5 U of Perfect Taq Red Polymerase (Central
European Biosystems, Prague, Czech Republic) and approximately
40 ng of tail DNA. PCR reaction was performed using the DNA
Engine DyadH Peltier Thermal Cycler (Bio-Rad, Hercules, CA),
according to the following scheme: an initial hot start 3 min at
94uC, followed by 40 cycles of 94uC for 30 s for denaturing, 55uC
for 60 s for annealing (except marker D7Mit259, for which optimal
Ta=52uC), 72uC for 60 s for elongation, and finally 3 min at 72uC
for final extension. Each PCR product was electrophoresed in 3%
agarose gel containing 80% of MetaPhorH Agarose (Cambrex Bio
Science Rockland, Inc., Rockland, ME) and 20% of UltraPure
TM
Agarose (Invitrogen, Carlsbad, CA) for 15 min to 2 h at 150 V.
Precision mapping of Tbbr2
To map precisely Tbbr2 on STS derived segment of strain CcS-
11 on proximal part of chromosome 12 [32] we used 8
microsatellite markers: D12Mit10a, D12Mit11, D12Mit209,
D12Mit182, D12Mit104, D12Mit240, D12Mit170, Dtnb (dystro-
brevin, beta) and 4 SNPs; rs48212577, rs4229232, rs50154157
and rs50776991 (Generi Biotech, Hradec Kra ´love ´, Czech
Republic). The conditions of PCR reaction were as described in
the section Genotyping of F2 mice.
PolymorphismofSNPs wastested byrestriction analysisafter PCR
reaction using following restriction enzymes (New England BioLabs,
Ipswich, MA): HpyAV for rs48212577 (14,13 ml of PCR product, 2
U( 1ml) of HpyAV, 1.7 ml of 10x NEB buffer 4 [200 mM Tris-
acetate, 500 mM Potassium Acetate, 100 mM Magnesium Acetate,
10 mM Dithiothreitol, pH 7.9], 0.17 mlo f1 0m g / m lB S A( b o v i n e
serum albumin), 37uC, o/n); HinfI for rs4229232 (14.8 mlo fP C R
product, 5 U (0,5 ml) of HinfI, 1.7 ml of 10x NEB buffer 4, 37uC, o/
n); BsmFI for rs50154157 (14,13 ml of PCR product, 2 U (1 ml) of
BsmFI, 1.7 ml of 10x NEB buffer 4, 0.17 ml of 10 mg/ml BSA, 65uC,
o/n), and Tsp509I for rs50776991 (14,8 ml of PCR product, 2 U
(0,5 ml) of Tsp509I, 1.7 ml of 10x NEB buffer 1 [100 mM Bis-Tris-
propane-HCl, 100 mM MgCl2, 10 mM Dithiothreitol, pH 7.0],
65uC, o/n). The products were electrophoresed in 3% agarose gel
containing 80% of MetaPhorH Agarose (Cambrex Bio Science
Rockland, Inc., Rockland, ME) and 20% of UltraPure
TM Agarose
(Invitrogen, Carlsbad, CA) for 15 min to 2 h at 150 V.
Statistical analysis
For the strain pattern analyses, differences in survival after T. b.
brucei infection were compared between the RC strains CcS-5, CcS-
11, CcS-16 and CcS-20 and the parental strains BALB/c and STS
by Kaplan-Meier estimator using the PROC LIFETEST procedure
of the SAS 9.1 statistical package for Windows (SAS Institute, Inc.,
Cary, NC). The differences between strains BALB/c, STS and CcS-
11 in splenomegaly, hepatomegaly and body weight change were
evaluated by the analysis of variance (ANOVA) and Newman-Keuls
multiple comparison using the program Statistica for Windows 8.0
(StatSoft, Inc., USA). Strain and age were fixed factors and
individual experiments were considered as a random parameter.
The differences in parameters between strains were evaluated using
the Newman-Keuls multiple comparison test at 95% significance.
DifferencesbetweenstrainsBALB/c,STSandCcS-11inchemokine
and cytokine levels were calculated by Mann Whitney U test.
Linkage of microsatellite markers with survival after T. b.
brucei infection in F2 hybrids was examined by analysis of
variance (ANOVA, PROC GLM statement of the SAS 8.2 for
Windows (SAS Institute, Inc., Cary, NC)). Log10 transformation
was performed in order to obtain normal distribution. The effect
Genetics of Resistance to Trypanosoma brucei
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tested. Each individual marker and its interactions with other
markers and sex or experiment were subjected to ANOVA. A
backward elimination procedure [33] was used. The first round
of the backward elimination procedure results in a list of
significant markers and a list of interactions. This list (the
markers and interactions with P value smaller than 0.05) is the
input for the second round of ANOVA and the marker (or
interaction) bearing the highest P value (if P.0.05) is
eliminated. The backward elimination procedure was repeated
till the final set of significant markers and interactions was
obtained.
To obtain genome-wide significance values (corrected P), the
observed P-values (aT) were adjusted according to Lander and
Schork [34] using the formula:
aT & Cz2rGh(T) ½  aT
where G=1.75 Morgan (the length of the segregating part of the
genome: 12.5% of 14 M); C=8 (number of chromosomes
segregating in cross between CcS-11 and BALB/c, respectively);
r=1.5 for F2 hybrids; h(T) =the observed statistic (F ratio).
Figure 1. Differential survival of BALB/c, STS and selected RC strains after T. b. brucei infection. Survival of A. females or B. both sexes
after intra-peritoneal inoculation of 2.5610
4 bloodstream forms of T. b. brucei. 10 females and 10 males from each strain were used for experiment.
The only exception was strain CcS-16, where we infected 9 females and 9 males.
doi:10.1371/journal.pntd.0001173.g001
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Differences among mouse strains in survival after T. b.
brucei infection
We have compared survival of strains BALB/c, STS/A, CcS-5,
CcS-11, CcS-16 and CcS-20 after infection with T. b. brucei.
Parental strains BALB/c and STS did not differ in survival. RC
strains CcS-5, CcS-16, and CcS-20 did not significantly differ in
survival from the background parental strain BALB/c. CcS-11
mice exhibit shorter survival than BALB/c mice after challenge
with T. b. brucei infection (P=0.0032 females, P=0.000093 both
sexes) (Figure 1 A,B). Some BALB/c mice survived up to 16 days,
whereas none of the CcS-11 mice lived longer than 10 days. Strain
CcS-11 was therefore selected for further analysis.
We have compared splenomegaly, hepatomegaly, changes of
body weight (Figure 2), and differences in cytokine and chemokine
Figure 2. Differences in splenomegaly, hepatomegaly and
changes in body weight after T. b. brucei infection. Female mice
strains of BALB/c (17 infected, 16 non-infected), STS (17 infected, 13
non-infected) and CcS-11 (18 infected, 16 non-infected) were com-
pared. Animals were intra-peritoneally inoculated with 2.5610
4
bloodstream forms of T. b brucei. Control, non-infected mice were kept
in the same animal facility. Both groups were killed after 10 days of
infection. The data show the means 6 SD from three independent
experiments. Asterisks indicate significant difference from BALB/c.
doi:10.1371/journal.pntd.0001173.g002
Figure 3. Differences in chemokine levels in strains BALB/c, STS
and CcS-11 after T. b. brucei infection. Female mice strains of BALB/
c (11 infected tested 2
nd day p.i., 22 infected tested 10
th day p.i., 22 non-
infected), STS (9 infected tested 2
nd day p.i., 17 infected tested 10
th day,
13 non-infected) and CcS-11 (14 infected tested 2
nd day p.i., 25 infected
tested 10
th day p.i., 26 non-infected) were compared. Animals were
intra-peritoneally inoculated with 2.5610
4 bloodstream forms of T. b.
brucei. Control, non-infected mice were kept in the same animal facility.
Mice were killed 10 days after inoculation. The data show the means 6
SD from three independent experiments. Asterisks indicate significant
difference from BALB/c.
doi:10.1371/journal.pntd.0001173.g003
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strain STS and RC strain CcS-11. Non-infected mice do not differ
in spleen to body weight ratio (Figure 2A) and in changes of body
weight (Figure 2C), whereas liver to body weight was higher in
BALB/c than in both STS (P,0.0000001) and CcS-11
(P,0.0000001) (Figure 2B). Infection led to a significant
enlargement of spleens (BALB/c: P=0.000001; STS:
P=0.000004; CcS-11: P=0.000001) and livers (BALB/c:
P=0.000001; STS: P=0.0007; CcS-11: P=0.000001) in all
tested strains and to decrease of body weight (BALB/c:
P=0.00068; STS: P=0.000044; CcS-11: P=0.00037) in com-
parison with non-infected mice. BALB/c exhibited higher
splenomegaly than STS (P,0.0000001) and CcS-11
(P,0.0000001) and also higher hepatomegaly than both STS
(P,0.0000001) and CcS-11 (P,0.0000001). Differences in
changes in body weight during the infection were observed
between BALB/c and STS (P=0.0080).
Serum levels of CCL7/MCP-3, CCL2/MCP-1, CCL3/MIP-1a,
CCL4/MIP-1b, CCL5/RANTES, GM-CSF and TNF-a were
measured at day 2 and 10 p.i. and compared with cytokines and
chemokines serum levels of non-infected control mice. We did not
observe any differences in GM-CSF levels between infected and non-
infected mice. At day 2 p.i. all tested strains had increased levels of
CCL7/MCP-3 in comparison with controls and in STS was also
observed increased level of CCL5/RANTES. At day 10 p.i. all three
tested strains exhibited increase of CCL7/MCP-3, CCL2/MCP-1,
CCL3/MIP-1a, CCL4/MIP-1b, CCL5/RANTES, and TNF-a
(Table S2, Figure 3, Figure S1). In infected mice, strain differences
from BALB/c were observed in serum levels of CCL2/MCP-1,
CCL3/MIP-1a and CCL7/MCP-3 (Figure 3). STS mice had lower
serum level of CCL2/MCP-1 day 2 p.i. (P=0.032) (Figure 3A) and
higherlevelofCCL3/MIP-1aday 10 p.i. (P=0 . 0 2 8 )(F i g u re3 B )t h a n
BALB/c. STS mice had lower serum level of CCL7/MCP-3 than
BALB/c day 2p.i. (P=0.019),whereasCcS-11 had lower serum level
of this chemokine than the background parental strain BALB/c day
10 p.i. (P=0.013) (Figure 3C).
Genetic loci that control survival after infection with T. b.
brucei
We examined survival after T. b. brucei infection in 169 F2
hybrids between the strains BALB/c and CcS-11. The strain CcS-
11 differs from BALB/c in the genetic material at 8 chromosomes
that were received from STS [32]. These differential STS-derived
segments were genotyped in the F2 hybrid mice using 14
microsatellite markers. Statistical analysis of linkage revealed four
genetic loci that influence survival after T. b. brucei infection. Two
of these loci have individual effects (Table 1); the other two operate
in mutual non-additive interaction (Table 2). The effects of all loci
were more expressed in females than in males.
Two loci, Tbbr1 (Trypanosoma brucei brucei response 1) linked to
D3Mit45 (corrected P value=0.0494 females; corr. P=0.267 both
sexes) and Tbbr2 linked to D12Mit37 (corrected P value=0.0224
females; corr. P value=0.0583 both sexes) have main effects on
survival that are not dependent on or influenced by interaction
with other genes (main effects) (Table 1, Figure 4 A,B,C,D). These
loci have in CcS-11 an opposite effect on the studied trait. The
homozygosity for the STS allele of Tbbr1 (SS) determines about 4
days longer survival than homozygosity of the BALB/c allele (CC),
whereas homozygosity for the STS allele of Tbbr2 (SS) is associated
with about three days shorter survival than the homozygosity of
the BALB/c allele (CC). We have also observed a suggestive
linkage of survival to D8Mit85 (corrected P value=0.0542
females; corr. P=0.0994 both sexes), heterozygotes had the
shorter survival (Table 1).
Tbbr3 linked to D7Mit282 influences survival in interaction with
Tbbr4 linked to D19Mit51 (corrected P=0.0332 females; corr.
P=0.0430 both sexes). F2 mice with homozygous BALB/c (CC)
alleles at Tbbr3 and STS (SS) alleles at Tbbr4 or homozygous for
STS allele at Tbbr3 and homozygous for BALB/c alleles in Tbbr4
have the shorter survival in comparison with other combinations
of Tbbr3 and Tbbr4 STS and BALB/c alleles (Table 2, Figure 4
E,F). A suggestive linkage was detected in females in interaction of
D8Mit85 and D19Mit60 (corrected P=0.0555), shorter survival
has been observed in mice heterozygous both in D8Mit85 and
D19Mit60 (Table 2).
Precision mapping of Tbbr2
Tbbr2 maps in CcS-11 to a rather short STS-derived region on
proximal part of chromosome 12, with previously estimated length
of 6 cM [32,35]. In order to map this locus more precisely, we
genotyped this region with 8 microsatellite markers and 4 SNPs.
This led to precision mapping of Tbbr2 to a region with a maximal
length of 2.15 Mb that contains only 26 genes (Figure 5).
Discussion
CcS-11 differs in susceptibility to trypanosomiasis from
both parental strains
CcS-11 differs in susceptibility to trypanosomiasis from both
parental strains. The background strain BALB/c is susceptible to
Table 1. Loci controlling survival after T. b. brucei infection - Single gene effect.
Marker Group Genotype P value corr. P value
CC CS SS
D3Mit45 females 15.8860.36 (n=18) 16.9860.41 (n=48) 19.5860.93 (n=19) 0.0010 0.0494
(Tbbr1) both sexes 15.1760.35 (n=39) 15.7360.33 (n=96) 17.2260.40 (n=34) 0.0077 NS (0.267)
D8Mit85 females 18.3260.86 (n=20) 15.9960.38 (n=44) 18.0360.85 (n=20) 0.0011 0.0542 (suggestive)
both sexes 16.9860.40 (n=43) 15.1460.35 (n=89) 15.9960.37 (n=36) 0.0024 NS (0.0994)
D12Mit37 females 19.2360.90 (n=15) 17.2960.43 (n=53) 15.8960.36 (n=15) 0.0004 0.0224
(Tbbr2) both sexes 17.0660.40 (n=32) 15.7460.27 (n=98) 15.3860.35 (n=37) 0.0013 0.0583 (suggestive)
F2 hybrids between CcS-11 and BALB/c were tested. Means and standard errors of means of survival times and P-values were computed by analysis of variance.
Logarithmic (Log10) transformation was used to obtain normal distribution and the obtained values were retransformed after calculation. Number of tested mice is
shown in brackets.
doi:10.1371/journal.pntd.0001173.t001
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groups [15,16]. Donor strain STS does not differ in survival from
the background strain BALB/c, however the strain CcS-11 that
contains a set of approximately 12.5% genes of the donor strain
STS and 87.5% genes of the background strain BALB/c and it has
shorter survival after infection than either parent. The elements in
the BALB/c genome that work in interaction with STS disease
response loci can be identified in linkage tests as gene-gene
interactions. For example, in the interaction of Tbbr3 and Tbbr4,
the survival of mice with homozygous BALB/c alleles at both loci,
or homozygous STS alleles at both loci is longer than of mice that
are homozygous for BALB/c allele at one locus and homozygous
for the STS allele at the second (Table 2A). The fine mapping and
molecular identification of Tbbr4 will reveal one of BALB/c
elements that can modify the effect of STS genes. The RC strains
are especially suitable to detect such interactions [36].
The observations of progeny having a phenotype, which is
beyond the range of the phenotype of its parents are not rare in
traits controlled by multiple genes. Some F2 hybrids derived in
cross between trypanotolerant African N’Dama (Bos taurus) and
trypanosusceptible Kenya Boran (Bos indicus) cattle differed from
both parents and contained less T. congolense parasites than any of
them [37]. Similarly, mouse RC strain OcB-9 differs from both
parental strains O20 and B10.O20 in response to alloantigens
[38], several RC strains exhibit in some parameters higher
susceptibility to Leishmania major than both parental strains BALB/c
and STS [39], and analysis of gene expression from livers in
chromosome substitution strains (background strain C57BL/6,
donor strain A/J) revealed that only 438 out of 4209 expression
QTLs were inside the parental range [40]. These observations are
due to multiple gene-gene interactions of QTLs, which in new
combinations of these genes in RC strains, F2 hybrids or in
chromosomal substitution strains can lead to appearance of new
phenotypes that exceed their range in parental strains. Also, with
traits controlled by multiple loci, the parental strains often contain
susceptible alleles at some of them and resistant on others, and
some progeny may receive predominantly susceptible alleles from
both parents.
We have compared in strains BALB/c, STS and CcS-11
splenomegaly, hepatomegaly, changes of body weight (Figure 2),
and cytokine and chemokine levels (Figure 3). However, none of
these measurements explains differences in survival between
BALB/c and CcS-11. BALB/c and CcS-11 also do not differ in
parasitemia day 10 p.i. (data not shown). Thus, the identification
of Tbbr1-Tbbr4 genes is needed to provide information about the
mechanisms controlling differences in survival between these
strains.
Susceptibility loci and potential candidate genes
We have detected four loci that in the strain CcS-11 control
survival after T. b. brucei infection and mapped them with a
precision of 1 cM–25 cM (Tables 1, 2, Figure 5). Usually, a
standard inbred-strain mapping experiment using F2 hybrids will
map a QTL onto a 20- to 40-cM interval [41]. Using advanced
intercross lines [20,22] the susceptibility loci Tir1 and Tir3c to T.
congolense were mapped with a 95% confidence interval to 1.3 and
2.2 cM, respectively. In the RC strains the donor-derived
segments of medium length (5–25 cM) comprise 54% of donor
genome [42]. However, RC strains can carry on some
chromosomes very short segments of donor strain origin. This
feature of the RCS system allowed us previously to narrow the
location of Lmr9 (Leishmania major response 9) on chromosome 4 to
a short segment of 1.9 cM without any additional crosses [43].
The short length of this segment, which controls levels of serum
IgE in L. major infected mice, enabled us to map a human homolog
of this locus on human chromosome 8 and show that it controls
susceptibility to atopy [44].
Our data show sex influence on survival as after correction for
the genome-wide testing significance of the Tbbr loci was detected
only in females or in the whole tested group. This observation can
be related to the influential role of sex hormones in control of
parasitic infections by their ability to modulate different compo-
Table 2. Interaction between loci that control survival after T.
b. brucei infection.
A. Females
P=0.0009 Corrected P=0.0332
D19Mit51 (Tbbr4)
CC CS SS
D7Mit282 CC 18.4661.32 18.7960.88 16.0860.74
(Tbrr3) (n=6) (n=11) (n=9)
CS 18.1460.85 17.7760.86 17.0160.81
(n=9) (n=18) (n=9)
SS 14.9061.06 17.3360.82 18.6660.88
(n=5) (n=9) (n=6)
P=0.0016 Corrected P=0.0555
D19Mit60
CC CS SS
D8Mit85 CC 18.9661.36 16.6860.78 19.4561.39
(n=5) (n=8) (n=7)
CS 17.0660.76 15.0560.36 15.9460.77
(n=10) (n=23) (n=11)
SS 16.9661.20 20.1361.44 17.1660.78
(n=5) (n=7) (n=8)
B. Both sexes
P=0.0013 Corrected P=0.0430
D19Mit51 (Tbbr4)
CC CS SS
D7Mit282 CC 16.6360.79 17.0260.40 15.2460.72
(Tbbr3) (n=11) (n=19) (n=12)
CS 16.4460.79 16.2160.39 15.7060.37
(n=19) (n=40) (n=24)
SS 13.9960.67 16.4860.38 16.9060.80
(n=9) (n=22) (n=10)
P=0.0420 Corrected P=NS
D19Mit60
CC CS SS
D8Mit85 CC 18.2060.85 16.1160.75 16.9060.80
(n=8) (n=18) (n=17)
CS 15.9260.31 14.5960.33 14.9660.35
(n=20) (n=49) (n=20)
SS 15.8460.76 16.9060.80 15.2460.72
(n=9) (n=16) (n=11)
F2 hybrids between CcS-11 and BALB/c were tested. Means and standard errors
of means of survival times and P-values were computed by analysis of variance.
Logarithmic (Log10) transformation was used to obtain normal distribution and
the obtained values were retransformed after calculation. Number of tested
mice is shown in brackets.
doi:10.1371/journal.pntd.0001173.t002
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Greenblatt and Rosenstreich [47] analyzed resistance of the 10
inbred mouse strains and two sets of F1 hybrids to infection with T.
b. rhodesiense. C3H/HeN, C3H/HeJ, CBA/J, BALB/c and CBA/
CaJ were highly susceptible, with mean survival times of less than
22 days, and did not exhibit differences in survival between males
Figure 4. Differential survival of F2 hybrid mice after T. b. brucei infection. Mice were intra-peritoneally inoculated by 2.5610
4 bloodstream
forms of T. b. brucei. A. females and B. both sexes carrying BALB/c or STS homozygous alleles in Tbbr1 (D3Mit45); C. females and D. both sexes
carrying BALB/c or STS homozygous alleles in Tbbr2 (D12Mit37); E. females and F. both sexes carrying interacting STS homozygygous alleles in Tbbr3
(D7Mit282) and BALB/c homozygous alleles in Tbbr4 (D19Mit51) or BALB/c homozygous alleles in Tbbr3 and heterozygotes in Tbbr4. n, number of
mice.
doi:10.1371/journal.pntd.0001173.g004
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C57BL/6J, C57BL/KsJ, C57BL/10SnJ, (BALB/c x C57BL/6)F1
and (C57BL/66 BALB/c)F1 female mice were more resistant
than males. These data support the finding of different genetic
regulation of susceptibility to T. brucei in males and females in
certain genetic combinations. Genes controlling infections that
Figure 5. Position of the loci that control response to T. b. brucei in strain CcS-11. The regions of STS and BALB/c origin are represented as
dark and white, respectively; the boundary regions of undetermined origin are shaded. Only the markers defining the boundaries the STS-derived
segment and the markers that were tested for linkage are shown. The markers that exhibit significant P values (corrected for genome-wide search)
are shown in bold.
doi:10.1371/journal.pntd.0001173.g005
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pathogens. For example, Rmp4 (resistance to mouse pox 4) controls
susceptibility to ectromelia virus in female mice only [48] and Hrl
(herpes resistance locus) exhibits higher influence on susceptibility
to Herpes simplex virus in male than in female mice [49]. Sex
specific QTLs influence also susceptibility to Theiler’s murine
encephalomyelitis virus-induced demyelination: loci Tmved7 and 8
affect male mice only, whereas locus Tmved9 controls susceptibility
only in females. Locus Tmved6 operates both in females and males,
but it has an opposite effect on disease susceptibility in males and
females [50]. Lmr20 influenced IgE level in L. major infected
females, but not in males [35]. QTLs Cnes1 and Cnes2 were
associated with high pulmonary Cryptococcus neoformans burden in
females, whereas Cnes3 was associated with fungal pulmonary
burden in male mice [51]. QTL on chromosome 17 controls
susceptibility to pulmonary infection with Chlamydia pneumoniae, but
has much stronger effect in males, whereas QTL on chromosome
5 controls susceptibility only in female mice [52]. In humans, for
example the IL9 genetic polymorphism (rs2069885) has an
opposite effect on the risk of severe respiratory syncytial virus
bronchiolitis in boys and girls [53].
In the present study, we were able to precision map Tbbr2 to
2.15 Mb. This segment contains 26 genes, 12 of them are either
predicted genes or cDNA sequences (Table 3). Public databases
(http://www.ncbi.nlm.nih.gov; http://www.informatics.jax.org
and http://biogps.gnf.org/#goto=welcome) show that some of
these genes are in non-infected mice expressed in tissues such as
liver, spleen, and brain (Table 3). These organs are in infected
mice affected by parasite [6,7]. There is no obvious candidate
gene and there are only indirect indications about the possible
role of some of these genes, such as Dnmt3a (DNA methyltrans-
ferase 3a)[54],[55], Pomc (pro-opiomelanocortin-alpha) [56,57],
Adcy3 (adenylate cyclase 3) [58], and Ncoa1 (nuclear receptor
coactivator 1) [59] in immune response against Trypanosoma.
Tbbr1 is localized in the distal part of chromosome 3. Potential
candidate genes in this locus are Ptgfr (prostaglandin F receptor)
[MGI:97796] and Ptger3 (prostaglandin E receptor 3 (subtype
EP3)) [MGI:97795], as prostaglandins play a suppressive role in
infection with African trypanosomes [60].
Tbbr3 on chromosome 7 and Tbbr4 on chromosome 19 map
near to the genes Cd19 [MGI:88319] and Cd5 [MGI:88340],
respectively, that code markers of B lymphocytes. CD19 is a B-
Table 3. Expression of genes in locus Tbbr2 in liver, spleen and brain of non-infected animals.
Gene ID Liver Spleen Brain
NCBI,MGI BioGPS NCBI,MGI BioGPS NCBI,MGI BioGPS
Gm11061, predicted gene 11061 MGI:3779285 NT NT NT NT NT NT
Dnmt3a, DNA methyltransferase 3A MGI:1261827 YES ,,M YES .M YES .M
Gm10485, predicted gene 10485 MGI:3641689 NT NT NT NT NT NT
Pomc, pro-opiomelanocortin-alpha MGI:97742 NO ,, NO ,, YES ,,
Efr3b, EFR3 homolog B (S. Cerevisiae) MGI:2444851 NO .M NO .M YES .M
Dnajc27, Dnaj (Hsp40) homolog, subfamily C, member 27 MGI:2443036 NO ,MN O ,M YES .30xM
Adcy3, adenylate cyclase 3 MGI:99675 YES ,M YES .M YES .3M
Cenpo, centromere protein O MGI:1923800 YES ,MN O ,M YES ,M
2410017P09Rik, RIKEN cDNA 2410017P09 gene MGI:1916959 YES .M NO ,M YES .M
Ncoa1, nuclear receptor coactivator 1 MGI:1276523 YES ,M YES ,M YES .3xM
Gm3613, predicted gene 3613 MGI:3781789 NO NT NO NT NO NT
Gm3620, predicted gene 3620 MGI:3781796 NO .M NO .M NO .M
Gm3625, predicted gene 3625 MGI:3781801 NO NT YES NT YES NT
Itsn2, intersectin 2 MGI:1338049 YES ,M YES .3xM YES .M
4930417G10Rik, RIKEN cDNA 4930417G10 gene MGI:1922105 NO .M NO ,M YES .M
A830093I24Rik, RIKEN cDNA A830093I24 gene MGI:2442121 YES .M* NO .M* YES .M*
Pfn4, profilin family member 4 MGI:1920121 NO ,M** NO NT YES ,M**
Gm6682, predicted gene 6682 MGI:3647156 NT .M NT ,MN T ,M
0610009D07Rik, RIKEN cDNA 0610009D07 gene MGI:1913305 YES ,M YES .M YES ,M
Fkbp1b, FK506 binding protein 1b MGI:1336205 NO ,MN O ,M YES ,M
BC068281, cDNA sequence BC068281 MGI:3040699 YES .3xM YES .M YES .M
Mfsd2b, major facilitator superfamily domain containing 2B MGI:3583946 NO ,M YES ,MN O ,M
Ubxn2a, UBX domain protein 2A MGI:2442310 YES .M YES .M YES .3M
Atad2b, ATPase family, AAA domain containing 2B MGI:2444798 YES ,M YES .M YES .M
Klhl29, kelch-like 29 (Drosophila) MGI:2683857 NO ,MN O .3M YES .30xM
2810032G03Rik, RIKEN cDNA 2810032G03 gene MGI:1919919 NO .M NO ,M YES .3xM
Data were compiled from public databases (Http://www.ncbi.nlm.nih.gov; http://www.informatics.jax.org) February 25, 2011 and http://biogps.gnf.org/
#goto=welcome, February 25, 2011). NCBI/MGD: YES – expression of a gene was observed; NO – expression of a gene was not observed; NT – not tested. BioGPS:
Majority of data were obtained using Gene Atlas MOE430, *Gene Atlas GNF1M, **Gene Atlas U133A. M=median value across all samples for a single probe set. NT – not
tested.
doi:10.1371/journal.pntd.0001173.t003
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shown that in murine experimental T. brucei trypanosomiasis, B-
cells were crucial for periodic peak parasitemia clearance and
survival of host [16]. CD5
+ subpopulation of B-1 cell has been
found to be stimulated by different Trypanosoma species: T. cruzi
[62], T. b. evansi [63], and T. congolense [64]. These B-cells were the
main source of antibodies reactive with non-parasite antigens in T.
congolense-infected cattle [64].
However, genes that are presently not considered as possible
candidates might cause the effects of some or all Tbbr loci.
Moreover, not only genes, but also noncoding RNAs in Tbbr loci
region may influence the outcome of infection [65].
Are Tbbr loci involved in control of other pathogens?
Some genes, for example Slc11a1 (solute carrier family 11
(proton-coupled divalent metal ion transporters), member 1) or
Lyst (lysosomal trafficking regulator) /beige have been found to
control susceptibility to several pathogens (reviewed in ref [29]).
Tbbr2 might be potentially involved also in control of Leishmania
major, as it overlaps with locus Lmr22 (Leishmania major response 22),
which in interaction with Lmr5 controls serum IL-4 in L. major
infected mice [35], whereas Tbbr3 on chromosome 7 maps near to
Ity7 (immunity to S. typhimurium 7) [66].
Control of susceptibility to T. congolense is exercised by loci on
chromosomes 17, 5 and 1 [19,22], whereas susceptibility to T. cruzi
is determined by loci on chromosomes 17 and 5 [23]. Influence of
loci on chromosomes 17 and 5 could not be tested in the present
cross, as CcS-11 does not carry STS-derived segments on these
chromosomes [32]. STS-derived region present on chromosome 1
of CcS-11 overlaps with Tir3c [22], however we did not detect
influence of this segment on susceptibility to T. b. brucei. This might
be caused either by differences in regulation of immunity against
the sub-genus T. (Nannomonas) congolense and the subgenus T.
(Trypanozoon) brucei, or because the Tir3c, which was detected in a
cross between strains C57BL/6J and BALB/c [19] and C57BL/6J
and A/J [22] is not polymorphic between strains BALB/c and
STS tested in this paper. Therefore the possible effects of Tbbr loci
in infection with other Trypanosoma species have yet to be
established.
In summary, this study represents the first definition of genetic
loci controlling susceptibility to T. b. brucei infection. One of them,
Tbbr2 is precisely mapped to the segment that contains only 26
genes, which will facilitate the identification of the candidate gene.
T. brucei subspecies cause sleeping sickness in humans and affect
also all livestock, with particularly severe effects in horses and dogs
[1]. Thus, the definition of genes controlling anti-parasite
responses might also permit a better understanding of pathways
and genetic diversity underlying the disease phenotypes in humans
and domestic animals.
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